Barclays’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Barclays’s Portfolio IMGO Stock Details IMGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-12,378	Closed	-$445K	–	5567
2022 Q4	$445K	Buy	12,378 +11,207	+957%	+$280K	﹤0.01%	3383
2022 Q3	$18K	Sell	1,171 -204	-15%	-$3.31K	﹤0.01%	4108
2022 Q2	$19K	Sell	1,375 -2,958	-68%	-$47K	﹤0.01%	4435
2022 Q1	$83K	Buy	+4,333	New	+$89.9K	﹤0.01%	3872

Barclays's IMGO Position: Q1 2023 in Review

Barclays sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 12,378 shares — an estimated $445K sold.

Barclays first reported a position in IMGO in Q1 2022 and held it in 4 quarters. The position peaked at $445K in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

Barclays reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
Barclays sold 12,378 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $445K.
Barclays first reported a position in Imago BioSciences, Inc. Common stock in Q1 2022 and held it in 4 quarters.
Barclays's Imago BioSciences, Inc. Common stock position peaked at $445K in Q4 2022.
0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.